Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
69
8 regions31 stories17 countries
Europe
9 stories- What to expect from new UK medical cannabis programme
GBMedicallink no longer available
- Academy of Medical Cannabis launches online learning platform for UK doctors
GBMedicallink no longer available
- Many medical cannabis patients in UK will still have trouble accessing treatment
GBMedicallink no longer available
- Shares of Danish company Stenocare quadruple on first day of IPO
DKBusiness & Investmentlink no longer available
- Poll finds 59% of British public support medical cannabis legalisation
GBRegulationlink no longer available
- Beleave signs supply agreement with German medical cannabis company Canymed
DEBusiness & Investmentlink no longer available
- Cannabis Europa targets France as special committee conducts medical cannabis study
FRMedicallink no longer available
- Canadian companies continue to use Germany as entry point for EU markets
DEBusiness & Investmentlink no longer available
- Despite lack of clarity, two cannabis producers claim cultivation licences in Greece
GRRegulationlink no longer available
United States
1 story- US Speaker Paul Ryan says CBD is proven medical treatment
USHemp & CBDlink no longer available
Canada
1 story- Canadian cannabis firms 48North and Good & Green merge in $18m deal
CABusiness & Investmentlink no longer available
LATAM & Caribbean
4 stories- Mexico's Supreme Court overturns absolute ban on recreational cannabis
MXRegulationlink no longer available
- Brazil's president-elect seeks to introduce outdated drug policies
BRRegulationlink no longer available
- Uruguayan medical cannabis company Cannapur considers filing an IPO
UYBusiness & Investmentlink no longer available
- Pivot Pharma creates joint venture with Mexico-based Intercontinental Marketing Co
MXBusiness & Investmentlink no longer available
Africa & Middle East
1 story- Lesotho becomes hotspot for Canadian cannabis companies
LSBusiness & Investmentlink no longer available
APAC
2 stories- Thai government considers draft bill for medical cannabis legalisation
THRegulationlink no longer available
- Japan, South Korea and China warn citizens to avoid cannabis in Canada
JPKRCNRegulationlink no longer available
Oceania
7 stories- Seven people a day approved for medical cannabis in Australia
AUMedicallink no longer available
- Health officials in Australia apologise for six-month delay in issuing cannabis licences
AURegulationlink no longer available
- Australian company RotoGro acquires Canadian cannabis processor Supra THC
AUBusiness & Investmentlink no longer available
- Vanuatu government will issue five cannabis cultivation licences
VURegulationlink no longer available
- Australian cannabis companies competing for billion dollar market share
AUBusiness & Investmentlink no longer available
- Sydney-based investor Farjoy increases holding in Medlab Clinical
AUBusiness & Investmentlink no longer available
- Australia's medical cannabis industry could expand to 200x current size in a decade
AUMedicallink no longer available
Rest of world
2 stories- Anheuser-Busch monitoring cannabis market closely
Business & Investmentlink no longer available
- Coca-Cola backtracks on cannabis-infused drinks
Business & Investmentlink no longer available
Health & Science
- Endogenous sex hormones modulate cannabinoid sensitivity
Health & Sciencelink no longer available
- Stanford scientists form company to develop CBD treatments for inflammatory diseases
USHealth & Sciencelink no longer available
- Australian scientists study whether high-THC can kill brain cancer cells
AUHealth & Sciencelink no longer available
- Runner's high caused by increased circulation of endocannabinoids
Health & Sciencelink no longer available
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report